Navigation Links
Eppendorf Video Features Dr Andrew Holt's Work on Bioactive Leachates From Plastic Consumables
Date:12/2/2011

HAMBURG, Germany, December 2, 2011 /PRNewswire/ --

Cross reference: Picture is available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/18701/eppendorf-ag?keygroup=bild

In a well-received report in Science from 2008, Dr. Andrew Holt and his group from the University of Alberta, Canada, described how chemicals used as manufacturing additives can substantially inhibit enzymatic assays and binding studies by leaching into samples from plastic consumables. Eppendorf recently visited Dr. Holt's pharmacology lab with a film crew to ask him how experimental data can be affected and what he recommends to other scientists to ensure unaffected and reproducible results.

Daniel Wehrhahn, product manager responsible for consumables at Eppendorf, commented: 'Dr. Holt's results clearly show that using pipette tips and microcentrifuge tubes from manufacturers that can confirm the absence of critical production additives leads to experimental results which are much more reliable and reproducible. Eppendorf high quality consumables are manufactured only from virgin polypropylene certified free of plasticizers, biocides or other unwanted additives which could leach into buffers and solvents, leading to false positive or false negative results in bioassays. Our material also complies with the FDA requirements for olefin polymers.'

Launched via the Eppendorf consumables web page, YouTube and social networking sites, the new video will quickly gain worldwide exposure, helping other researchers choose plastic consumables which are best suited to their assays. Scientific background information, recent publications and application data is also available on the website.  

Eppendorf's clean-room manufacturing processes are fully automated and subject to continuous quality monitoring. In addition, fully-automated production and special optimised molds that work without slip agents - such as Oleamide or DiHEMDA - ensure that epT.I.P.S. pipette tips®, Eppendorf Tubes® and Eppendorf Plates® satisfy the requirements of demanding applications. Batch-specific purity certificates can be downloaded from the Eppendorf website.

http://www.eppendorf.com/consumables

A Video interview with Dr. Andrew Holt is available at:

http://www.youtube.com/watch?v=LR1ljpp9TDE

 

Press contact:
Eppendorf AG
Bettina Doerler
public relations officer
doerler.b@eppendorf.de
+49-40-538-01-640



'/>"/>
SOURCE Eppendorf AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
2. Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
3. Eppendorf AG Deploys a Strategic Information Management Solution on a Global Level
4. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
5. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
10. Video: Keppra XR(TM) Approved in the U.S.
11. Video: Fortune 1000 Executives: New President Must Fix Education Gap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... LAFAYETTE, Indiana (PRWEB) , ... ... ... division of Albany Molecular Research Inc. has further extended its industry leading ... This service offers state-of-the-art cGMP techniques and methods for the ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... -- A new independent identity strategy consultancy firm announces ... Designed to fill a critical niche in technical and ... Mark Crego and Janice Kephart ... expertise that span federal governments, the 9/11 Commission, private ... expertise has a common theme born from a shared ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
Breaking Biology News(10 mins):